Keyword :
Select Report Type :
Select Industry :
Select Sector :
Select Category :
Select Geography :

Search Results

Report Title
Price
Europe Wound Care Market - Growth Assessment, Trends and Forecast Through 2019   $5,509
  • Language: | #Pages: 343 | Published: Nov-2014 | Region: Global
Single User price :$5,509 Add To Cart
Enterprise Price :$11,018 Add To Cart
Global Corporate Price :$16,527 Add To Cart

The Market Intelligence report provides critical market data for wound care and its product categories for the European region and its countries; France, Germany, Italy, Spain and the UK. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.
 
It’s vital “cross category comparison” and “cross sub-category comparison” section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.
 
It covers important categories such as traditional wound care, wound dressings, negative pressure wound therapy (NPWT), wound closure devices, ostomy bags, compression therapy.
 
Market Size
Market size in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019.

Market Growth
Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019.
 
Competitive Analysis 
Market share (%) of companies is covered at sector and category level for 2013.
 
Pricing Analysis
Average selling price ($) for each product type from 2006 – 2013 and forecast till 2019.
 
Cross category comparison and cross sub-category comparison – Forecast and historic market growth and market size comparison for various categories and sub-categories from 2006 to 2013 and 2013 to 2019.

Point of Sales Share - Hospital and Home care

Recent Events and Developments

Wound Care Market Segmentation
 
Traditional Wound Care
Wound Dressings
    Semi-Permeable Films
    Foams
    Alginates & Hydrofibres
    Hydrocolloids
    Hydrogels
    Interactive Dressings
       Collagens
Negative Pressure Wound Therapy (NPWT)
Wound Closure Devices
    Hemostats
    Tissue Sealants
    Skin Closure Devices
 Ostomy Bags
 Compression Therapy
Note*
Market segmentation - Sector>Category>Sub-Category>Segment

Global Oncology Market - Trends, Forecast and Pipeline Analysis   $7,219
  • Language: English | #Pages: 280 | Published: Nov-2014 | Region: Global
Single User price :$7,219 Add To Cart
Enterprise Price :$14,509 Add To Cart
Global Corporate Price :$21,637 Add To Cart

 Global Oncology Market to hit $109 billion – Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies

  • 18 drugs constitute ~75% of the global oncology market; one-third of these drugs are growing annually above 30%  
  • VEGF (Vascular Endothelial Growth Factor) is the mascot among top targets/pathways

Cancer, with a death toll exceeding that of AIDS (Acquired Immune Deficiency Syndrome), tuberculosis and malaria collectively, accounted for 8.3 million deaths in 2013. With a skyrocketing incidence of 469.6 per 100,000 in the US alone, the oncology market is poised to grow at a substantial CAGR of around seven percent to $109 billion by 2020. Targeted therapy class is the ‘top dog’ among all therapy segments with nearly ~3x the combined market of cytotoxic and hormonal therapy. “Growth factors such as EGF (Epidermal Growth Factors) and VEGF govern around half of the oncology therapy market, and have changed the landscape of pipeline and LCM (Life Cycle Management) strategies, outstripping the orthodox indications approach,” said ABMRG’s analyst Hardik Sharma. Although in last two years, a plethora of targeted drugs has been launched and is in development, price pressures have started popping up due to high scrutiny from payers, physicians and governments.

F. Hoffmann-La Roche AG ($RHHBY), Novartis AG ($NVS) and Celgene Corporation ($CELG) are the top three players, collectively accounting for ~70% of the entire market, followed by Johnson & Johnson ($JNJ), AstraZeneca plc (NYSE: AZN; LSE: AZN), Bristol-Myers Squibb ($BMY) and Pfizer, Inc ($PFE).  Other major players include Merck & Co. Inc. ($MRK), GlaxoSmithKline plc ($GSK), Eli Lilly and Company ($LLY), Bayer AG ($BAYN), Amgen ($AMGN), AbbVie ($ABBV), Sanofi S.A. ($SAN).

With almost every drug growing annually above 10%, Roche is the market leader and front-runner in life-cycle management of oncology drugs, as it holds the highest number of in-line extensions (ILEs), which comprise around half of its entire pipeline. The words of Roche CEO Severin Schwan—“We go where the science takes us”—demonstrates its focus on bolt-on acquisitions compared with a transformational approach. Celgene also shares the same philosophy as evident from its recent deal with OncoMed.

Novartis, which has the most robust oncology pipeline with multi-fold NMEs than Roche, has adopted multi-pronged—bolt-on and transformational—growth strategy. This is evident from its recent $90 million deal with Oxford Biomedica for boosting its cancer immunotherapy portfolio and the acquisition of complete oncology unit of GlaxoSmithKline plc.

“In an era of consolidation, where companies like Novartis acquired oncology business of GSK and Pfizer made endless attempts to buy out AstraZeneca, at least a couple of M&As in oncology space are expected in the short term by pharma juggernauts eying on the high-growth oncology market to overcome the ‘dried-up’ pipelines and looming patent expirations,” said ABMRG CEO Manoj Jiandani.

Avastin is the leader with sales of $6.7 billion in 2013 and in the short- to mid-term it is forecast to sustain its position supported by its extensive pipeline and entrenched indications base. Meanwhile, in the long term, Revlimid is expected to dominate due to its extensive pipeline, prolonged patent term and impressive CAGR of more than 40%.

Global cancer burden is expected to get nearly doubled to more than 21 million cases and 13 million deaths by 2030. Owing to high unmet needs, the oncology market would continue to grow at a moderate pace, driven by rising aging population, hopping incidence rates, expedited FDA approvals, booming urbanisation, enhanced diagnosis and rising adoption of combination therapies. Conversely, sky-high prices, limited reimbursement, high patient out-of-pocket costs and lack of screening and awareness in developing regions are the major restraints.

Although, cancer continues to be a major health challenge in the developed world, driven by modern lifestyle patterns, more than 60% of world’s new annual cases originate from Africa, Asia and Central and South America, which together account for nearly three-fourths of the world’s cancer deaths. Among developing economies, India, China and Russia account for ~40% of world’s population with around 2x the cancer mortality rates compared with that in the US and the UK.

Key Questions Answered:

 

  • Which are the probable game-changers in terms of drug, therapy class and player?
  • Which are the high-growth segments and expected potential targets/pathways?
  • Which are the top 35 oncology drugs and leading market players globally?
  • How did new drugs evolve into blockbusters and what are the strategies behind it?
  • What is the estimated market size and market forecast?
  • What are the major market drivers and restraints globally and in key geographies?
  • How is the competitive outlook in terms of key products, pipeline and players?
  • What are unmet needs and opportunities in the oncology market?

Single User price :$2,900 Add To Cart
Enterprise Price :$5,800 Add To Cart
Global Corporate Price :$8,700 Add To Cart
This research report provides key market trends, market forecasts and competitive scenario of the Cerebral Spinal Fluid Management Devices (CSF) in China through 2020.
 
 The product categories covered in this report include: 
 
 •  CSF Shunt
 
 •  ICP Monitoring Devices
 
 Scope
 
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
 
• Highlights and compares key product categories for growth trends and revenue forecast.
 
• Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
 
• Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 
 
• Market share of companies.
 
• Average selling price ($) for each product type (2007 to 2020).
 
• Recent Events and Developments.
 
 Why should you buy?
 
• Build business strategy by identifying the high growth and attractive market categories. 
 
• Develop competitive strategy based on competitive landscape. 
 
• Design capital investment strategies based on forecasted high potential segments. 
 
• Identify potential business partners, acquisition targets and business buyers. 
 
• Plan for a new product launch and inventory in advance. 
 
• Prepare management and strategic presentations using the market data. 
 

• To review unbiased and independent assessment of the market data.  

Australian Diabetes Management Devices Market, 2007 - 2020   $4,249
  • Language: English | #Pages: 55 | Published: Nov-2014 | Region: Global
Single User price :$4,249 Add To Cart
Enterprise Price :$8,498 Add To Cart
Global Corporate Price :$12,747 Add To Cart

.....

APAC Joint Replacement And Joint Reconstruction Market Through 2020   $7,309
  • Language: English | #Pages: 109 | Published: Nov-2014 | Region: Global
Single User price :$7,309 Add To Cart
Enterprise Price :$14,618 Add To Cart
Global Corporate Price :$21,927 Add To Cart

.... 

Europe Diabetes Management Market Outlook Through 2020   $5,509
  • Language: English | #Pages: 140 | Published: Nov-2014 | Region: Global
Single User price :$5,509 Add To Cart
Enterprise Price :$11,018 Add To Cart
Global Corporate Price :$16,527 Add To Cart
The Market Intelligence report provides critical market data for China diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. 
 
It s vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.
 
It covers important categories such as blood glucose monitoring systems and insulin delivery devices.
 
Market Size 
Market size in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2020. 
 
Market Growth
Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2020. 
 
Competitive Analysis 
Market share (%) of companies is covered at sector and category level for 2013.
 
Pricing Analysis
Average selling price ($) for each product type from 2006-2013 and forecast till 2020.
 
Cross category comparison and cross sub-category comparison Forecast and historic market growth and market size comparison for various categories and sub-categories from 2006 to 2013 and 2013 to 2020. 
 
Recent events and developments
 
Diabetes Management Devices Market Segmentation
Blood Glucose Monitoring Systems
Blood Glucose Meters
Blood Glucose Test Strips
Continuous Glucose Monitoring Systems
Continuous Glucose Monitors (CGM)
CGM Sensors
Insulin Delivery Devices
Insulin Pens
Reusable Insulin Pens
Disposable Insulin Pens
Insulin Syringes
Insulin Pumps
 
China Diabetes Management Devices Market, 2007 - 2020   $5,509
  • Language: English | #Pages: 45 | Published: Nov-2014 | Region: Global
Single User price :$5,509 Add To Cart
Enterprise Price :$11,018 Add To Cart
Global Corporate Price :$16,527 Add To Cart

The Market Intelligence report provides critical market data for China diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. 

 

It s vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.

 

It covers important categories such as blood glucose monitoring systems and insulin delivery devices.

 

Market Size 

Market size in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2020. 

 

Market Growth

Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2020. 

 

Competitive Analysis 

Market share (%) of companies is covered at sector and category level for 2013.

 

Pricing Analysis

Average selling price ($) for each product type from 2006-2013 and forecast till 2020.

 

Cross category comparison and cross sub-category comparison Forecast and historic market growth and market size comparison for various categories and sub-categories from 2006 to 2013 and 2013 to 2020. 

 

Recent events and developments

 

Diabetes Management Devices Market Segmentation

Blood Glucose Monitoring Systems

Blood Glucose Meters

Blood Glucose Test Strips

Continuous Glucose Monitoring Systems

Continuous Glucose Monitors (CGM)

CGM Sensors

Insulin Delivery Devices

Insulin Pens

Reusable Insulin Pens

Disposable Insulin Pens

Insulin Syringes

Insulin Pumps

 

India Joint Reconstruction Market Trends Forecast To 2020   $5,509
  • Language: English | #Pages: 64 | Published: Nov-2014 | Region: Global
Single User price :$5,509 Add To Cart
Enterprise Price :$11,018 Add To Cart
Global Corporate Price :$16,527 Add To Cart

This research report provides key market trends, market forecasts and competitive scenario of the joint reconstruction in India through 2020.

 

The product categories covered in this report include: 

Hip Replacement

Knee Replacement

Shoulder Replacement

Small Joints

 

 

Scope

 

The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 

Highlights and compares key product categories for growth trends and revenue forecast.

Market size, annualized revenue and unit sales for each product category from 2007 to 2020.

Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 

Market share of companies.

Average selling price ($) for each product type (2007 to 2020).

Recent events and developments

 

Why should you buy?

Build business strategy by identifying the high growth and attractive market categories 

Develop competitive strategy based on competitive landscape

Design capital investment strategies based on forecasted high potential segments

Identify potential business partners, acquisition targets and business buyers

Plan for a new product launch and inventory in advance

Prepare management and strategic presentations using the market data

European Hip Replacement Market Through 2020 - Opportunities, Trends And Pipeline Analysis   $5,509
  • Language: English | #Pages: 150 | Published: Nov-2014 | Region: Global
Single User price :$5,509 Add To Cart
Enterprise Price :$11,018 Add To Cart
Global Corporate Price :$16,527 Add To Cart

The Market Intelligence report provides critical market data for hip implants and its segments for the European region and its 15 countries in detail; EU15. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.

 

It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.

 

It covers important categories such as Total Hip Replacement (THR) - primary hip replacement, revision hip replacement, partial hip replacement, cemented hip replacement, noncemented hip replacement (cement less hip replacement)

 

Market Size - Individual Countries and Continent

Market size of hip implants in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2020. 

 

Market Growth - 15 Individual Countries and Continent

Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2020. 

 

Competitive Analysis - 15 Individual Countries and Continent level

Market share (%) of companies for hip replacement implants for 2013.

 

Pricing Analysis - 15 Individual Countries and Continent level

Average selling price ($) for each product type from 2006 to 2014 and forecast till 2020.

 

 

Cross Category Comparison - 15 Individual Countries and Continent level

Cross category comparison and cross sub-category comparison Forecast and historic market growth and market size comparison for various categories and sub-categories from 2006 to 2013 and 2013 to 2020.

 

Market Dynamics

    Market Trends

    Market Drivers and Restrains

 Recent Industry Activity - Global

M&A

Partnerships

Product Approvals

Product Launches

Recalls

Litigations

This report is useful for -

-       Market expansion and market entry strategy

-       Product, production and inventory planning

-       Product management

-       Management and investors presentations

-       Due diligence to identify targets for M&A

.-      Tracking present and future competition

-       Identifying in-licensing and out-licensing partners

-       Venture capitalists, Investment banks, Angel investors

-       Management consultants

-       Governments, trade and commerce organizations

-       Research institutes

How this report is different -

-       Wide coverage of geographies

-       Bottom-up approach

-      Companies from various levels of value chain

-     Projections based on detailed and rigorous primary research to validate optimistic and pessimistic approach

-     Used advanced computational, robust statistical and analytical models

-     Considered mid and late stage assets

Brands Studied

Contemporary

Elite Plus Ogee

Elite Plus Cemented Cup

Marathon

Exeter Rimfit

Exeter Duration

ZCA

Opera

Low Profile Muller

Stanmore-Arcom Cup

Charnley Ogee

Charnley Cemented Cup

Wroblewski Golf Ball

CCB Mathys

Reflection Cemented

Zimmer Cemented Cup

Cenator Cemented Cup

Apollo

SHP Cup

Chirulen

Aeon Cemented Cup

JRI Cemented Cup

Interplanta

Novae Stick

Metasul-Muller

Exceed ABT Cemented

Snap Fit

CMK Cemented Cup

Link Flange Cup

Avantage Cemented Cup

Edinburgh Cup

Polarcup Cemented

CCB

Freedom

Centerpulse Muller

Restoration Gap2

A Class

Scan Cemented Cup

Hi-Nek Cemented Cup

Ultima Cemented Cup

Novae Stick

Gap Ring

Exeter Rimfit

Contemporary

Marathon

Elite Plus Ogee

Elite Plus Cemented Cup

Novae Stick

US Joint Reconstruction Market Outlook and Trends Until 2020   $5,509
  • Language: English | #Pages: 109 | Published: Nov-2014 | Region: Global
Single User price :$5,509 Add To Cart
Enterprise Price :$11,018 Add To Cart
Global Corporate Price :$16,527 Add To Cart
This research report provides key market trends, market forecasts and competitive scenario of the joint reconstruction US through 2020.
 
The product categories covered in this report include: 
Hip Replacement
Knee Replacement
Shoulder Replacement
Small Joints
 
 
Scope
 
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
Highlights and compares key product categories for growth trends and revenue forecast.
Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 
Market share of companies.
Average selling price ($) for each product type (2007 to 2020).
Recent events and developments
 
Why should you buy?
Build business strategy by identifying the high growth and attractive market categories 
Develop competitive strategy based on competitive landscape
Design capital investment strategies based on forecasted high potential segments
Identify potential business partners, acquisition targets and business buyers
Plan for a new product launch and inventory in advance

Prepare management and strategic presentations using the market data 

 1    2   | 3   | 4   | 5   | >   | >>   

Page 1 of 227   showing records 1 to 10 of 2265 in this selection